Shalby’s step-down subsidiary, Shalby Global Technologies (SGT), Singapore, has received regulatory approval from Indonesia’s Ministry of Health to market and sell knee implants, hip systems, knee and hip instruments, and so on. SGT can now import the aforementioned implants and medical devices from the United States and sell them in Indonesia.
The development is entirely consistent with the stated strategy of expanding the implant business and establishing a global footprint in the medical device market. The Shalby group has reached a significant milestone in its quest to serve many more international patients. The synergies between the businesses are compelling, and the benefits of sourcing US FDA-approved quality implants into Indonesia through our distribution channels will be realised immediately.
Shalby has performed over 1,44,000 joint replacement surgeries to date and continues to be the leader in India and globally in terms of annual surgery volume.